Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-03

Clinical Trial Update: Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy [NA]

View source ↗

Summary

A completed clinical trial evaluating Integrated Coping Awareness Therapy for stress reactivity in schizophreniform disorders; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Schizophreniform Disorders | NA | Status: COMPLETED | Results posted: 2021-03-03